• Profile
Close

Long-term prognosis of patients with HHV-6 reactivation following allogeneic HSCT

Pediatrics International Mar 24, 2018

Iesato K, et al. - The long-term clinical complications and prognosis among patients undergoing hematopoietic stem cell transplantation (HSCT) experiencing HHV-6 reactivation during the early phase following HSCT were studied. A connection between HHV-6 reactivation with acute graft-versus-host disease (GVHD), but not with chronic GVHD, engraftment, or overall survival was demonstrated. Nonetheless, it was determined that the onset of HP was associated with lower overall survival.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay